Insights and examples of how collaborative efforts can lead to the development of innovative therapies that target unmet patient needs.
Bertrand Ducrey
Advertisement
Bertrand Ducrey, Ph.D., is the CEO of Debiopharm, a Swiss-based global biopharmaceutical company.
Articles by Bertrand Ducrey
Advertisement
Latest Updated Articles
The Importance of Collaborative Business Models for Drug DevelopmentPublished: April 27th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
2
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
3
Henlius Enters Global Exclusive License Agreement with U-mab Biopharma for Best-in-Class Potential Anti-IL-1RAP mAb
4
Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma
5